Show
Sort by
-
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma
-
Quantitative perfusion scintigraphy or anatomic segment method in lung cancer resection
-
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study
-
Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country
-
Asthma, atopy and COPD in sub-Saharan countries : the challenges
-
- Journal Article
- A1
- open access
Inaccurate clinical nodal staging of non-small-cell lung cancer: evidence fro mthe MRC LU22 multicentre randomised trial
-
The role of EBUS-TBNA for the assessment of hilar lymph nodes
-
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
-
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
-
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer
-
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population
-
Association of TGFβ1 polymorphisms involved in radiation toxicity with TGFβ1 secretion in vitro
-
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients
-
Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer
-
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer : a randomized trial
-
Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer
-
The emerging role for combined endosonography with fine needle aspiration in lung cancer staging is the scope the right one?
-
- Journal Article
- A2
- open access
Endurance and resistance training in radically treated respiratory cancer patients: a pilot study
-
Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients
-
The IASLC Lung Cancer Staging Project A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer
-
What is the role for surgery in patients with stage III non-small cell lung cancer ?
-
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum
-
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01) a randomised clinical trial
-
A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials
-
Palliative chemotherapy: do we need yet another end-point?
-
EBUS TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy
-
EBUS-TBNA for the Clarification of PET Positive Intra-Thoracic Lymph Nodes-an International Multi-Centre Experience
-
Glomerular filtration rate is a confounder for determination of serum soluble mesothelin
-
Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study
-
Soluble mesothelin as a tool for early detection of malignant mesothelioma in asbestos-exposed workers
-
Trimodality treatment of early stage Malignant Pleural Mesothelioma (MPM): a single institutional experience
-
The International Association for the Study of Lung Cancer Staging Project Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer
-
The IASLC Lung Cancer Staging Project Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer
-
Endoscopic and Endobronchial Ultrasonography According to the Proposed Lymph Node Map Definition in the Seventh Edition of the Tumor, Node, Metastasis Classification for Lung Cancer
-
Targeted therapies in the treatment of advanced/metastatic NSCLC
-
Response to chemotherapy predicts longer survival in an individual patient meta-analysis of 1205 patients with mesothelioma
-
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor as biomarkers of mesothelioma
-
Development and external validation of a nomogram for prediction of radiation-induced dysphagia in 493 lung cancer patients treated with chemo-radiotherapy or radiotherapy alone
-
A pilot phase II clinical trial of the 20S proteasome inhibitor bortezomib in patients with relapsed malignant pleural mesothelioma
-
The IASLC Lung Cancer Staging Project Data Elements for the Prospective Project
-
Is clinical to pathological (c to p) stage migration another Will Rogers phenomenon? An analysis of the IASLC staging database
-
Toxicity of EORTC 08031: phase 11 feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for malignant pleural mesothelioma (MPM) cT3N1M0 or less
-
Association of TGFβ1 polymorphisms involved in radiation toxicity with TGFβ1 secretion in vitro
-
Soluble mesothelin as a monitoring tool in the management of malignant mesothelioma patients
-
Pemetrexed (P) and Cisplatin (C) as either Induction (IC) or Adjuvant (AC) Chemotherapy in stage IB-II Non-Small Cell Lung Cancer (NSCLC): A randomized phase 2 study (EORTC 08051)
-
Muscle force and mass in patients with respiratory cancer: effects of radical treatment
-
Quantitative Perfusion Scintigraphy (QPS) or the Anatomic Segment Method (ASM) for estimating Postoperative Pulmonary Function (PF) in patients treated for non-small cel lung cancer (NSCLC): a retrospective comparison
-
Epidermal growth factor receptor protein expression and gene amplification in Caucasian patients with malignant pleural mesothelioma (MPM)
-
Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments
-
To what degree do patients with advanced lung cancer want to be informed and involved in medical decision-making?: a multicentre study in 13 hospitals in Belgium
-
Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma
-
What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC?
-
Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group
-
Behandeling van het maligne pleuramesothelioom.
-
De rol van adjuvante chemotherapie bij volledig gereseceerde niet-kleincellige longkanker.
-
A guide to staging in lung cancer, but potentially misleading without attention to the details
-
The controversial role of surgery in stage III NSCLC
-
Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: A phase I study
-
Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: Present status and future prospects
-
The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition
-
Advances in the systemic therapy of malignant pleural mesothelioma
-
FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels
-
Single-agent pemetrexed for chemonaive and pretreated patients with malignant pleural mesothelioma - Results of an International Expanded Access Program
-
The yield of endoscopic ultrasound in lung cancer staging: Does lymph node size matter?
-
- Miscellaneous
- open access
The sound of the parasite. diagnosing mediastinal cysts with endoscopic ultrasound techniques
-
Development, external validation and further improvement of a prediction model for survival of non-small cell lung cancer patients treated with (Chemo)radiotherapy
-
Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk
-
Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer - Response
-
- Journal Article
- A1
- open access
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: A prospective study
-
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer
-
Neoadjuvant chemotherapy in early stage non-small cell lung cancer
-
Evidence-based supportive management in lung cancer
-
Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancer
-
Lessons to learn from EORTC study 08981: A feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer
-
Predicting risk of radiation-induced lung injury
-
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
-
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
-
Symptoms and patient-reported well-being: Do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma
-
Transoesophageal endoscopic ultrasound with fine needle aspiration (EUS-FNA) in lung cancer staging: does lymph node size matter?
-
The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant
-
Extrapleural pleuropneumonectomy in selected patients with epitheloid or biphasic pleural mesothelioma
-
Re-188-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study
-
Pemetrexed in thoracic cancer
-
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)
-
Chemotherapy in malignant mesothelioma: What's up, doc?
-
Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage - Reply
-
Combination chemotherapy: Moving beyond pemetrexed
-
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975
-
Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study
-
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
-
Systemic therapy of bronchioloalveolar carcinoma: Results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
-
Treatment compliance and early toxicity of 3D involved-field radiotherapy (RT) and chemotherapy (CT) in a randomized study comparing induction CT followed by concurrent CT-RT with concurrent CT-RT followed by consolidation CT, in non-small-cell lung cancer (NSCLC)
-
Does downstaging in patients (pts) with IIIA-N2 non-small cell lung cancer (NSCLC) and a response to induction chemotherapy (ICT) influence outcome with surgery (S) or radiotherapy (RT)? An exploratory analysis of EORTC 08941
-
- Journal Article
- A1
- open access
A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndrome
-
Progression-free survival rate as primary end point for phase II cancer clinical trials: Application to mesothelioma - The EORTC Lung Cancer Group
-
Quality assurance of thoracic radiotherapy in EORTC 08941: A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy
-
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer
-
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
-
Morbidity and mortality in the surgery arm of EORTC 08941 trial
-
Consensus report: Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesothelioma